Cholinergic modulation of neostriatal output: A functional antagonism between different types of muscarinic receptors

Citation
E. Galarraga et al., Cholinergic modulation of neostriatal output: A functional antagonism between different types of muscarinic receptors, J NEUROSC, 19(9), 1999, pp. 3629-3638
Citations number
54
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROSCIENCE
ISSN journal
02706474 → ACNP
Volume
19
Issue
9
Year of publication
1999
Pages
3629 - 3638
Database
ISI
SICI code
0270-6474(19990501)19:9<3629:CMONOA>2.0.ZU;2-9
Abstract
It is demonstrated that acetylcholine released from cholinergic interneuron s modulates the excitability of neostriatal projection neurons. Physostigmi ne and neostigmine increase input resistance (R-N) and enhance evoked disch arge of spiny projection neurons in a manner similar to muscarine. Muscarin ic R-N increase occurs in the whole subthreshold voltage range (-100 to -45 mV), remains in the presence of TTX and Cd2+, and can be blocked by the re latively selective M-1,M-4 muscarinic receptor antagonist pirenzepine but n ot by M-2 or M-3 selective antagonists. Cs+ occludes muscarinic effects at potentials more negative than -80 mV. A Na+ reduction in the bath occludes muscarinic effects at potentials more positive than -70 mV. Thus, muscarini c effects involve different ionic conductances: inward rectifying and catio nic. The relatively selective M-2 receptor antagonist AF-DX 116 does not bl ock muscarinic effects on the projection neuron but, surprisingly, has the ability to mimic agonistic actions increasing R-N and firing. Both effects are blocked by pirenzepine. HPLC measurements of acetylcholine demonstrate that AF-DX 116 but not pirenzepine greatly increases endogenous acetylcholi ne release in brain slices. Therefore, the effects of the M-2 antagonist on the projection neurons were attributable to autoreceptor block on choliner gic interneurons. These experiments show distinct opposite functions of mus carinic M-1- and M-2-type receptors in neostriatal output, i.e., the firing of projection neurons. The results suggest that the use of more selective antimuscarinics may be more profitable for the treatment of motor deficits.